Literature DB >> 25529973

DNA damage at respiratory distress, but not acute time-points, correlates with tissue fibrosis following thoracic radiation exposure in mice.

Amit Kunwar1, Christina K Haston.   

Abstract

PURPOSE: Radiation exposure can result in DNA damage but whether the extent of DNA damage correlates with the radiation-induced tissue injury in the lung is not known. We aimed to determine whether numbers of γH2AX foci, representing histone H2AX phosphorylation a marker of DNA damage, measured within days of radiation exposure, correlated with known later lung injury responses in eight inbred mouse strains.
MATERIALS AND METHODS: Mice received 18 Gy pulmonary irradiation and numbers of γH2AX positive nuclei in the lung were immunohistochemically determined.
RESULTS: Numbers of γH2AX foci, assessed up to seven days post irradiation did not correlate with pulmonary fibrosis. γH2AX counts from mice in respiratory distress, however, significantly correlated with fibrosis and lungs from mice treated with a fibrosis-reducing antagonist had fewer γH2AX foci.
CONCLUSIONS: Acute response measures of pulmonary DNA damage did not predict for pathology, but levels of this marker in distressed mice were correlative of fibrosis.

Entities:  

Keywords:  Inbred mouse strains; double-strand breaks; fibrosis; thoracic irradiation

Mesh:

Substances:

Year:  2015        PMID: 25529973     DOI: 10.3109/09553002.2015.997897

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  9 in total

1.  Recurrent DNA damage is associated with persistent injury in progressive radiation-induced pulmonary fibrosis.

Authors:  Tyler A Beach; Angela M Groves; Carl J Johnston; Jacqueline P Williams; Jacob N Finkelstein
Journal:  Int J Radiat Biol       Date:  2018-09-21       Impact factor: 2.694

2.  Radiation induced pulmonary fibrosis as a model of progressive fibrosis: Contributions of DNA damage, inflammatory response and cellular senescence genes.

Authors:  Tyler A Beach; Carl J Johnston; Angela M Groves; Jacqueline P Williams; Jacob N Finkelstein
Journal:  Exp Lung Res       Date:  2017-05-23       Impact factor: 2.459

3.  γH2AX, a DNA Double-Strand Break Marker, Correlates with PD-L1 Expression in Smoking-Related Lung Adenocarcinoma.

Authors:  Eiko Sakurai; Hisato Ishizawa; Yuka Kiriyama; Ayano Michiba; Yasushi Hoshikawa; Tetsuya Tsukamoto
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

Review 4.  Modeling radiation-induced lung injury: lessons learned from whole thorax irradiation.

Authors:  Tyler A Beach; Angela M Groves; Jacqueline P Williams; Jacob N Finkelstein
Journal:  Int J Radiat Biol       Date:  2018-10-25       Impact factor: 2.694

5.  Radiation-induced lung damage promotes breast cancer lung-metastasis through CXCR4 signaling.

Authors:  Lynn Feys; Benedicte Descamps; Christian Vanhove; Anne Vral; Liv Veldeman; Stefan Vermeulen; Carlos De Wagter; Marc Bracke; Olivier De Wever
Journal:  Oncotarget       Date:  2015-09-29

Review 6.  Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rémy Guillevin; Jean-Noël Vallée
Journal:  Oncotarget       Date:  2017-09-23

7.  The Th1/Th17 balance dictates the fibrosis response in murine radiation-induced lung disease.

Authors:  Alexandra Paun; Marie-Eve Bergeron; Christina K Haston
Journal:  Sci Rep       Date:  2017-09-14       Impact factor: 4.379

8.  Half brain irradiation in a murine model of breast cancer brain metastasis: magnetic resonance imaging and histological assessments of dose-response.

Authors:  Niloufar Zarghami; Donna H Murrell; Michael D Jensen; Frederick A Dick; Ann F Chambers; Paula J Foster; Eugene Wong
Journal:  Radiat Oncol       Date:  2018-06-01       Impact factor: 3.481

9.  Huangqi Shengmai Yin Protects against Radiation-Induced Cardiac Fibrosis Injury by Regulating the TGF-β1/Smads and MMPs.

Authors:  Jing Gu; Yongqi Liu; Hongyan Wu; Hailong Li; Kai Liu
Journal:  Evid Based Complement Alternat Med       Date:  2019-05-13       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.